TITLE

SPECIAL REPORT: Defining A Future For Fee-For-Service Medicare

AUTHOR(S)
Foote, Susan Bartlett; Halaas, Gwen Wagstrom
PUB. DATE
May 2006
SOURCE
Health Affairs;May/Jun2006, Vol. 25 Issue 3, p864
SOURCE TYPE
Academic Journal
DOC. TYPE
Report
ABSTRACT
The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides economic incentives that favor health plans over traditional fee-for-service (FFS) Medicare. This reflects an ideological preference for private plans rather than government- administered pricing and recognition that private plans can use tools effectively to improve quality. However, enrollment projections indicate that FFS will continue to attract the majority of beneficiaries for years to come. We argue that MMA's contractor reform provisions create the opportunity to build critical FFS infrastructure, and contractors have the potential to encourage quality and manage utilization to compete with private plans in a modernized Medicare.
ACCESSION #
20935292

 

Related Articles

  • Medicare HMO Enrollment, Benefits Decline, Premiums Rise.  // hfm (Healthcare Financial Management);Feb2004, Vol. 58 Issue 2, p21 

    Reports on the decreased in the share of enrollees in plans with a zero premium option and an increased in average monthly premiums in the U.S. Percentage rate of Medicare beneficiaries; Total amount of limited brand-name coverage; Rate in plans covered by generic drugs.

  • MTM cost threshold may be $4,000.  // Drug Topics;2/21/2005, Vol. 149 Issue 4, p7 

    This article reports the drug cost threshold for Medicare beneficiaries to qualify for medication therapy management in the U.S.

  • Medicare Calibration of the Clinically Detailed Risk Information System for Cost. Kapur, Kanika; Chien-Wen Tseng; Rastegar, Afshin; Carter, Grace M.; Keeler, Emmett // Health Care Financing Review;Fall2003, Vol. 25 Issue 1, p37 

    The clinically detailed risk information system for cost (CD-RISC) contains definitions for several hundred severity-adjusted conditions that can be used to predict future health care costs. We develop a prospective Medicare CD-RISC model using a 5-percent sample of Medicare beneficiaries and...

  • Medicare's Private Plans: A Report Card On Medicare Advantage. Gold, Marsha // Health Affairs;Jan/Feb2009, Vol. 28 Issue 1, pw41 

    With higher payments and expanded private-plan authority, Medicare Advantage (MA) has caused the market to grow. One in three Medicare beneficiaries with Part D now gets this coverage through MA. Analysis of the sources of and reasons for enrollment growth suggest a troubling report card....

  • Capping drug benefits does not reduce total medical costs.  // PharmacoEconomics & Outcomes News;6/17/2006, Issue 505, p4 

    The article discusses research being done on the total medical costs of patients whose drug benefits were capped and those whose benefits were not capped. It references a study by J. Hsu and colleagues in the June 2006 issue of the "New England Journal of Medicine." The researchers used a...

  • Predictability of Prescription Drug Expenditures for Medicare Beneficiaries. Wrobel, Marian V.; Doshi, Jalpa; Stuart, Bruce C.; Briesacher, Becky // Health Care Financing Review;Winter2003, Vol. 25 Issue 2, p37 

    MCBS data are used to analyze the predictability of drug expenditures by Medicare beneficiaries. Predictors include demographic characteristics and measures of health status, the majority derived using CMS' diagnosis cost group/hierarchical condition category (DCG/HCC) risk-adjustment...

  • Trends in the Treatment of Acute Myeloid Leukaemia in the Elderly. Lang, Kathleen; Earle, Craig C.; Foster, Talia; Dixon, Deirdre; Gool, Renilt Van; Menzin, Joseph // Drugs & Aging;2005, Vol. 22 Issue 11, p943 

    Introduction: Acute myeloid leukaemia (AML) is the most common type of leukaemia among adults in the US. However, data on longitudinal treatment patterns and outcomes associated with AML and its relapse are sparse, particularly among the elderly. This study documents changes in treatment...

  • Riding The Rollercoaster: The Ups And Downs In Out-Of-Pocket Spending Under The Standard Medicare Drug Benefit. Stuart, Bruce; Briesacher, Becky A.; Shea, Dennis G.; Cooper, Barbara; Baysac, Fatima S.; Limcangco, M. Rhona // Health Affairs;Jul/Aug2005, Vol. 24 Issue 4, p1022 

    This study projects how much Medicare beneficiaries who sign up for the standard Part D drug benefit in 2006 will pay in quarterly out-of-pocket payments through 2008. In the first year we estimate that about 38 percent of enrollees will hit the benefit's no-coverage zone, known as the "doughnut...

  • Longevity and Health Care Expenditures: The Real Reasons Older People Spend More. Zhou Yang; Norton, Edward C.; Stearns, Sally C. // Journals of Gerontology Series B: Psychological Sciences & Socia;Jan2003, Vol. 58 Issue 1, pS2 

    Objectives. In this study, we investigated the relative contributions of both age and time to death to health care expenditures for elderly Medicare beneficiaries. We also analyzed differences in expenditure patterns by age and time to death for various service types and payers. Methods. We...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics